Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development.
Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.
Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA

Redwood City, US
Size (employees)
91 (est)-37%
Codexis was founded in 2002 and is headquartered in Redwood City, US

Key People at Codexis

John Nicols

John Nicols

President & CEO
Douglas Sheehy

Douglas Sheehy

Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary
David O'Toole

David O'Toole

Senior Vice President and Chief Financial Officer
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Office Locations

Codexis has office in Redwood City
Redwood City, US

Codexis Metrics

Codexis Summary

Market capitalization

$193.5 m

Closing share price

Codexis's current market capitalization is $193.5 m.

Codexis Financials

We estimate that Codexis's revenue is $48.8 m in 2016
FY, 2013FY, 2014FY, 2015Y, 2016


$31.9 m$35.3 m$41.8 m$48.8 m

Revenue growth, %


Net Income

($41.3 m)($19.1 m)($7.6 m)

Codexis Market Value History

Codexis Online Presence

Codexis Company Life

You may also be interested in